RECENT NEWS

Organisations representing hundreds of thousands of pregnant employees some of which are healthcare workers have expressed concern at the withdrawal without any warning of COVID-19 guidance by the Department of Health and Social Care (DHSC) for employers on how to protect pregnant employees.

Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.

The latest Health and Care Bill has now received Royal Assent, meaning it will now become law.

New guidelines aiming to support clinicians in the diagnosis of fibromyalgia syndrome (FMS) have been published by the Royal College of Physicians (RCP).

Dartford and Gravesham NHS Trust has entered the next stages in its digitisation journey with the procurement of two technologies that will alleviate pressure on emergency department staff, theatres and recovery.

The Government has tabled a landmark amendment to the Health and Care Bill aiming to eradicate the use of goods and services in the NHS that are tainted by slavery and human trafficking.

The world’s first Scalp Cooling Summit will unite global oncology and research thought leaders to discuss current practice and how to advance the future of scalp cooling and side effect management in cancer care.

The UK Health Security Agency (UKHSA), Public Health Scotland, Public Health Wales and the Public Health Agency are continuing to investigate a rise in cases of sudden onset hepatitis (liver inflammation) in children aged 10 and under since January 2022, where the usual viruses that cause infectious hepatitis (hepatitis A to E) have not been detected.

Two new antimicrobial drugs, cefiderocol and ceftazidime-avibactam, are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model, after NICE published draft guidance estimating their value to the NHS.

Analysis by the Health Foundation has revealed that life expectancy for women living in the poorest 10% of areas in England is lower than overall life expectancy in any OECD country, except for Mexico.

Dr. Thomas Waite will support Chief Medical Officer (CMO) Professor Chris Whitty as the deputy CMO (DCMO) leading on health protection, replacing Professor Jonathan Van-Tam who stepped down on 31 March 2022. His role will cover emergency response and preparedness, infectious diseases, vaccines and therapeutics.

A one-of-a-kind British technology that could help healthcare systems save millions in costs associated with missed, late and cancelled appointments is set for stateside success following a trade mission to Texas.

​Hundreds of people have been diagnosed with lung cancer earlier through NHS mobile trucks, as part of the biggest programme to improve early lung cancer diagnosis in health service history.

Sodexo’s healthcare teams have won three International Safety Awards from the British Safety Council, receiving the highest result, distinctions.

Health experts have called for a greater focus on care for older women and improved support services for people experiencing pregnancy loss to help shape the Government’s first-ever Women’s Health Strategy for England.

An emergency donation, made up of face masks, dressings, bandages, sanitiser, gowns and more, has been sent to Nova Poshta (Help Ukraine), a Ukrainian delivery service, who will distribute the supplies to those most in need.

The London Clinic has announced a partnership with Datar Cancer Services to provide precision oncology-based solutions to improve the detection and treatment of cancers.

UK-based Medovate has announced an agreement with AKSIA Healthcare FZC to distribute its SAFIRA (SAFer Injection for Regional Anaesthesia) product range in Saudi Arabia, the UAE and Bahrain.

Healthcare professionals across East Lancashire Hospitals NHS Trust will receive an upgrade in their patient flow technology, following an agreement with smart healthcare IT provider Alcidion to deploy Miya Flow.

The North East Innovation Lab, originally established as part of the region’s integrated COVID hub, has received an investment of £1.4 million to continue work on assessing and evaluating the next generation of diagnostic tests.